Aerie Pharmaceuticals reported $118.13M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Alimera Sciences ALIM:US $ 11.4M 1.09M
Amarin AMRN:US $ 364.74M 5.69M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Cara Therapeutics CARA:US $ 15.53M 358K
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Horizon Pharma HZNP:US $ 854.04M 1.23M
Insmed INSM:US $ 112.5M 12.84M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Novartis NOVN:VX SF 29880M 247M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Supernus Pharmaceuticals SUPN:US $ 234.71M 48.74M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
Valeant Pharmaceuticals VRX:CN $ 5437M 80M
Zoetis ZTS:US $ 1471M 620M
Zogenix ZGNX:US $ 78.43M 9.09M